Further to letter dated July 27, 2026, and in accordance with the requirements of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), UPL has informed that the Board of Directors at their meeting held today, Monday, August 3, 2026, considered and approved the unaudited consolidated and standalone financial results of the Company for the quarter ended June 30, 2026. The aforesaid financial results were reviewed by the Audit Committee before approval by the Board. Pursuant to Regulation 30 and 33 of the SEBI Listing Regulations, it has enclosed unaudited consolidated and standalone financial results for the quarter ended June 30, 2026, along with limited review reports issued by BSR & Co. LLP, Chartered Accountants, Statutory Auditors of the Company. The Board Meeting commenced at 01:30 PM and is in progress. The results were taken on record by the Board at 03:00 PM.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| UPL | 625.00 |
| PI Industries | 2830.00 |
| Bayer CropScience | 4299.80 |
| Sharda Cropchem | 827.80 |
| Sumitomo Chem. India | 515.95 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: